This HTML5 document contains 132 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
n10	http://dx.doi.org/10.1023/A:
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q33332446

rdf:type

wikibase:Item

schema:description

επιστημονικό άρθρο wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch 2000 թուականի Մարտին հրատարակուած գիտական յօդուած mokslinis straipsnis 2000年論文 naučni članak vitskapeleg artikkel tudományos cikk 2000年论文 vědecký článek artigo científico (publicado na 2000) wetenschappelijk artikel מאמר מדעי 2000年论文 articolo scientifico bilimsel makale научна статия artykuł naukowy 2000年論文 мақолаи илмӣ artigo científico (publicado na 2000) vedecký článok 2000年论文 мақолаи илмӣ ২০০০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico article scientifique (publié 2000) artikull shkencor 2000年论文 teaduslik artikkel 2000년 논문 2000年の論文 tieteellinen artikkeli im März 2000 veröffentlichter wissenschaftlicher Artikel 2000年论文 article científic 2000 nî lūn-bûn научная статья artículu científicu espublizáu en 2000 مقالهٔ علمی مقالة علمية article scientific 2000年論文 наукова стаття, опублікована в березні 2000 научни чланак 2000年论文 articol științific სამეცნიერო სტატია videnskabelig artikel (udgivet 2000) artikulong pang-agham научни чланак บทความทางวิทยาศาสตร์ 2000 թվականի մարտին հրատարակված գիտական հոդված vitenskapelig artikkel vetenskaplig artikel 2000年論文 scientific article scienca artikolo bài báo khoa học 2000年論文 سائنسی مضمون artículo científico publicado en 2000

p:P577

wds:Q33332446-383CBA06-C07B-49A0-9C53-24842433A13D

wdt:P577

2000-03-01T00:00:00Z

p:P2860

wds:Q33332446-02A239A7-65BE-454D-817A-F50E48F7C121 wds:Q33332446-196DF0BA-E180-421C-86B7-87C463FD690F wds:Q33332446-3150A4DE-C988-41C0-86EE-247174A4A7BD wds:Q33332446-5E3C6A99-9564-4F19-B8A2-42BBBBD66F2D wds:Q33332446-659302C2-2DFD-42A9-82AA-E91BB75C7EB2 wds:Q33332446-73A4ADC8-CEF4-4F7A-8D20-11D196C4D307 wds:Q33332446-97FF9F65-CCE5-4616-A13F-AA3B468C558B wds:Q33332446-FCE2EB25-BA2D-4AB9-971F-CC7EC1436E6A

wdt:P2860

wd:Q41144469 wd:Q45976411 wd:Q36138642 wd:Q37650345 wd:Q40867992 wd:Q45994601 wd:Q73153274 wd:Q59289264

p:P2093

wds:Q33332446-F831BA3E-BF34-409D-8141-0321CCD7DFDB wds:Q33332446-EEF8FF1F-32A2-4B4F-96AE-A1CB29117A7B wds:Q33332446-729A24A7-B98E-4C90-BF22-CFE7640BC899 wds:Q33332446-622FC88F-6661-4289-A09D-70823A6CA604 wds:Q33332446-3247733E-59E7-45B9-B349-55E36CAE5625 wds:Q33332446-0DDD9C38-CA86-4BB6-A5C8-540963298AB4

wdt:P2093

P Comella J Bryce G Comella V De Rosa F Ionna F Caponigro

rdfs:label

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

skos:prefLabel

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

schema:name

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

p:P50

wds:Q33332446-01D6C139-979E-499D-9228-EA9D8F6BFFFE wds:Q33332446-32182EAB-CC11-406B-B761-06C718CF2DD3

wdt:P50

wd:Q40122753 wd:Q42039575

p:P1476

wds:Q33332446-C6B7FA48-47D9-47BE-B4E0-B811C5EC96BF

wdt:P1476

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer

p:P304

wds:Q33332446-4CB303A3-9C14-41AE-AA27-953B0973E596

wdt:P304

339-342

p:P31

wds:Q33332446-4996332B-B159-4B4D-82DC-F26BAB16F79F

wdt:P31

wd:Q13442814

p:P921

wds:Q33332446-B8685949-C74F-4207-A059-FB47F4138B16 wds:Q33332446-778C2C79-4E0F-41F4-8D58-08EFDE512715 wds:Q33332446-80164309-7A90-4E07-9438-5D027A9982AD wds:Q33332446-3964D435-A398-4F11-9D87-8BBB40F3D90C

wdt:P921

wd:Q18966654 wd:Q18936 wd:Q18554836 wd:Q1783924

p:P698

wds:Q33332446-8F9E07AA-0469-4BA3-B951-68D566EA3783

wdtn:P698

n9:10811502

wdt:P698

10811502

p:P1433

wds:Q33332446-05C65C19-B625-40EE-9E4A-E285E69F3418

wdt:P1433

wd:Q326122

p:P433

wds:Q33332446-9A5E132D-60B4-41C5-914A-EEFCC822E688

p:P478

wds:Q33332446-D099DA22-3EC0-4985-AB19-3CC679D74D68

wdt:P433

3

wdt:P478

11

p:P356

wds:Q33332446-72B9C30A-52A2-492F-A531-F8BFD577C532

wdtn:P356

n10:1008319618638

wdt:P356

10.1023/A:1008319618638